Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYT003-QbG10 in Perennial Allergic Rhinoconjunctivitis
NCT00575003Phase 2Completed
- Sponsor
- Cytos Biotechnology AG
- Start
- Dec 2007
- Primary completion
- Mar 2009
- Modality
- Antisense DNA, Nanoparticles, Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 2 trial of CYT003-QbG10 in perennial allergic rhinoconjunctivitis, sponsored by Cytos Biotechnology AG. Started Dec 2007; status: completed.
02
Drugs
CYT003-QbG10
03
Conditions
perennial allergic rhinoconjunctivitis
Beyond the preview
Go deeper on NCT00575003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00575003.